Anti-CD38 antibody Injection Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China60 enrolled1 locationNCT06168851
Recruiting
Phase 2
Anti-CD38 Antibody Treating APS With Thrombocytopenia
ThrombocytopeniaAntiphospholipid Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled1 locationNCT05983952
Recruiting
Phase 2
Anti-CD38 Antibody Treating Evans Syndrome
TreatmentEvan Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled1 locationNCT06014775